• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Age-based screening for lung cancer may be more cost-effective and improve detection compared to current screening criteria in the United States

byAlex XiangandSimon Pan
January 13, 2026
in Chronic Disease, Oncology, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Current US Preventive Services Task Force (USPSTF) screening criteria for lung cancer excludes many at-risk individuals and has poor adherence – age-based screening is cost-effective and improves detection.

Evidence Rating Level: 2 (Good)

Current USPSTF guidelines for lung cancer screening includes patients aged 50-80 years, have ≥ 20 pack-years, and are currently smoking or or quit < 15 years ago. Low-dose computed tomography (LDCT) has been proven to be effective for early detection; however, participation rates remain below 15% of eligible individuals, and there exist multiple nontobacco risk factors in lung cancer development. The authors sought to determine what proportion of patients meet USPSTF criteria, and if age-based screening would improve detection and be cost-effective. This retrospective cohort study found that of 997 patients (median [IQR] age: 67 [18-99]; 58.0% female) diagnosed with lung cancer, 45 patients underwent LDCT screening. 35.1% met USPSTF screening criteria, and 12.6% of these patients underwent LDCT screening. Expanding criteria to age 40 to 85 years, 10 or more pack-years, and no cessation limit increased detection to 62.1% (619 of 997 patients). Age-based screening (40-85 years) captured 93.9% of cases and prevented 26,124 deaths annually (95% CI, 20,000-32,248 deaths annually) at $101,000 per life saved (95% CI, $82,000-$120,000). This study suggests current USPSTF guidelines have poor adherence and are insufficient at capturing the majority of patients with lung cancer. Age-based screening improves detection and is cost-effective.

Click here to read this study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

2 Minute Medicine Rewind February 16, 2026

AstraZeneca moves to own multimodal oncology AI with Modella

Tags: lung cancerlung cancer screeningoncologypulmonologyrespirologyscreening
Previous Post

Prehospital postintubation hypotension following traumatic brain injury is associated with increased mortality

Next Post

Low bicarbonate replacement fluid may lead to a more stable acid-base profile compared with high bicarbonate replacement fluid during continuous veno-venous hemofiltration

RelatedReports

2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026
Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026
Patients with advanced adenomas are at increased risk of developing colorectal cancer
AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026
Next Post

Low bicarbonate replacement fluid may lead to a more stable acid-base profile compared with high bicarbonate replacement fluid during continuous veno-venous hemofiltration

Elective colectomy associated with improved survival in ulcerative colitis

The incidence of hypertension and infections may increase with age among patients with ulcerative colitis treated with ozanimod

Lariat device for left atrial appendage exclusion associated with adverse events

2 Minute Medicine Rewind December 1st, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Poly-L-lysine-coated catheters are safe and well-tolerated in adults requiring short-term catheterization
  • Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
  • Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.